| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.69B | +13.9% |
| Cost of Revenue | $4.08B | +17.3% |
| R&D Expense | $282.0M | +5.9% |
| SG&A Expense | $1.18B | +6.2% |
| Operating Income | $223.4M | -14.0% |
| Interest Expense | $147.3M | +62.6% |
| Pre-tax Income | $167.0M | +0.5% |
| Income Tax | $90.4M | +94.0% |
| Net Income | $76.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $260.6M | -40.7% |
| Accounts Receivable | $1.89B | +22.9% |
| Inventory | $822.0M | +33.4% |
| Current Assets | $3.16B | +17.0% |
| Total Assets | $7.10B | +2.2% |
| Current Liabilities | $1.90B | +2.3% |
| Long-term Debt | $3.19B | +7.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$152.8M | -172.5% |
| Capital Expenditures | $100.0M | +36.2% |
| Investing Cash Flow | -$112.1M | +90.8% |
| Financing Cash Flow | $100.2M | -89.0% |
| Free Cash Flow | -$252.8M | -283.9% |
| -36.0% |
| EPS (Basic) | $0.20 | -41.2% |
| EPS (Diluted) | -$0.04 | -112.1% |
| Total Liabilities |
| $5.65B |
| +2.4% |
| Stockholders' Equity | $1.44B | +1.7% |